Analysis of the outcomes for selecting dexamethasone or methylprednisolone in treating PSM and SIPTW COVID-19 patients (N = 784)

PSM patients

SIPTW patients

Outcomes¹

Dexa

N (%)

Methyl

N (%)

95% C.I

p²

OR

P

Recovered

146 (37.2)

143 (36.6)

−6.4, 7.6

0.93

1.04

0.8

Residual symptoms³

13 (3.3)

12 (3.0)

−2.4, 2.9

1.0

1.62

0.3

Needs home O₂

193 (49.1)

174 (44.5)

−2.6, 11.8

0.22

0.75

0.055

Death

41 (10.4)

62 (15.8)

−10.4, 0.45

0.03

1.70

0.017